Alterations of alpha2 globulin and clinical response in patients with prostatic cancer following cryotherapy

R. J. Ablin, M. J. Gonder, W. A. Soanes

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Progressively elevated levels of serum α2 globulin reportedly occur in various malignant neoplasms, including prostatic cancer, with a progression from locally invasive to metastatic disease. Based upon these reports, it has been suggested that increased levels of α2 globulin may be of prognostic value, once the diagnosis has been obtained, as an indicator of the stage of prostatic malignancy. In an attempt to evaluate further the potential usefulness of alterations of α2 globulin in the study of prostatic cancer, the sera of 18 patients with prostatic malignancy were evaluated by cellulose acetate electrophoresis followed by densitometric quantitation prior to and following cryotherapy of their primary prostatic tumour. Observations suggest, pending evaluation of a larger patient population, that α2 globulin may in addition to its prognostic potential as applied to stage identification, provide an objective criterion for monitoring the clinical response of an individual following cryotherapy.

Original languageEnglish (US)
Pages (from-to)no.248
JournalProceedings of the American Association for Cancer Research
Volume16
Issue number66
StatePublished - 1975
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Alterations of alpha2 globulin and clinical response in patients with prostatic cancer following cryotherapy'. Together they form a unique fingerprint.

Cite this